Challenges in Diagnosing and Treatment Plan of Mucormycosis Pre and Post Pandemic

With the current pandemic sweeping the world, science and medicine are up against enemies they have never faced before or opponents that are weaker than themselves—viruses and finally other biotic beings. Researchers are working to detect and eradicate COVID-19 variants, but opportunistic fungal infections caused by other innocuous species are rearing their ugly heads. Mucorale species cause mucormycosis, sometimes known as "Black Fungus," an aggressive opportunistic fungal illness. It spreads via blood vessels and causes necrosis, ischemia, and thrombosis. Particularly vulnerable are those who already have immunosuppressive conditions, such as diabetes mellitus, cancer, or long-term immunosuppressive pharmaceutical use.Coronavirus disease-2019 (COVID-19)-associated mucormycosis proved to be devastating because of its high death rate.Since the primary care physician is often the patient's first and often their only point of contact with a healthcare professional (especially in poor nations), they are vital to the diagnosis and treatment of this illness. To reduce mortality, early detection and diagnosis are crucial, as are preventative measures to halt the growth of the brain. A multidisciplinary approach from several professions is necessary for effective diagnosis and treatment. Surgical debridement, antifungal treatment, and excision of the affected regions are the protocols that need to be followed. Post-operative anomalies result in impairments related to phonetics, function, and appearance. Positive outcomes have been observed in congenital abnormality prosthetic rehabilitation, especially in elderly and immunocompromised individuals.